CG Invites Co., Ltd. (KOSDAQ:083790)
1,270.00
-30.00 (-2.31%)
Jan 29, 2026, 3:30 PM KST
CG Invites Market Cap
CG Invites has a market cap or net worth of 99.96 billion as of January 29, 2026. Its market cap has decreased by -45.95% in one year.
Market Cap
99.96B
Enterprise Value
154.26B
Revenue
18.12B
Ranking
n/a
PE Ratio
n/a
Stock Price
1,270.00
Market Cap Chart
Since January 6, 2006, CG Invites's market cap has decreased from 137.39B to 99.96B, a decrease of -27.24%. That is a compound annual growth rate of -1.57%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 28, 2026 | 99.96B | -12.58% |
| Dec 30, 2025 | 114.34B | -38.17% |
| Dec 30, 2024 | 184.93B | -11.21% |
| Dec 28, 2023 | 208.28B | -13.64% |
| Dec 29, 2022 | 241.17B | -46.50% |
| Dec 30, 2021 | 450.79B | -45.11% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| EASY BIO,Inc. | 236.54B |
| Genexine | 233.31B |
| MedPacto | 232.73B |
| ENCell | 185.07B |
| Macrogen | 184.20B |
| GeneOne Life Science | 156.77B |
| IMB Dx | 133.59B |
| Oncocross | 114.46B |